Brazil cosmetic maker Natura swings to profit in Q2
Core earnings, as measured by recurring earnings before interest, taxes, depreciation and amortization (EBITDA), stood at 795.6 million reais, up 4.5% year-on-year.
In the earnings report, the company said it reclassified Avon International and Avon CARD as assets kept for sale.
($1 = 5.4421 reais)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
4 minutes ago
- Yahoo
Hanesbrands (HBI) Jumps 27.85% on $5-Billion Acquisition Reports
We recently published Hanesbrands Inc. (NYSE:HBI) is one of the best-performing stocks on Tuesday. Hanesbrands soared by 27.85 percent on Tuesday to close at $6.18 apiece as investor sentiment was bolstered by reports that it was set to be acquired by Canada-based Gildan Activewear for $5 billion. According to news reports citing an unnamed source privy to the matter, Gildan Activewear and Hanesbrands Inc. (NYSE:HBI) are currently in advanced discussions for the potential merger, which could be decided on by the end of the week. The reports said the talks could still go either way. Last week, Hanesbrands Inc. (NYSE:HBI) reported an impressive earnings performance in the second quarter and first half of the year. In the quarter period, the company swung to a net income of $81.6 million from a $298 million net loss in the same period last year. Net sales inched up by only 1.8 percent to $991 million from $973 million year-on-year. In the first half of the year, Hanesbrands Inc. (NYSE:HBI) netted $72.15 million, reversing a $337.5 million net loss in the same comparable period. Net sales also grew by 1.9 percent to $1.75 billion from $1.72 billion year-on-year. For the full-year period, Hanesbrands Inc. (NYSE:HBI) expects net sales to hit $3.53 billion, which includes projected headwinds of approximately $35 million from changes in foreign currency exchange rates. Copyright: disorderly / 123RF Stock Photo In the third quarter alone, net sales were targeted at $900 million, including projected headwinds of $7 million. While we acknowledge the potential of HBI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the .
Yahoo
4 minutes ago
- Yahoo
Sea Limited (SE) Soars 19% on Stellar Earnings
We recently published Sea Limited (NYSE:SE) is one of the best-performing stocks on Tuesday. Sea Limited snapped a two-day losing streak on Tuesday, closing 19.07 percent higher after rallying as high as 21.7 percent at intra-day trading, with investor sentiment bolstered by a stellar earnings performance in the second quarter of the year. In its updated report, Sea Limited (NYSE:SE) said net income increased by more than fivefold to $414 million from only $79.9 million in the same period last year. Revenues grew 38.2 percent to $5.2 billion from $3.8 billion year-on-year, on the back of strong revenues across all segments. In the first half, net income attributable to shareholders soared by 1,294 percent to $809 million from only $58.2 million in the same comparable period. Revenues grew by 34.67 percent to $10.1 billion from $7.5 billion year-on-year. 'Given the high potential of our markets and the stage we are at in our business now, we will continue to prioritize growth, which will pave the way for us to maximize our long-term profitability. At the same time, our company has reached a stage where we can pursue growth opportunities while improving profitability,' said Sea Limited (NYSE:SE) Chairman and CEO Forrest Li. Copyright: vadymvdrobot / 123RF Stock Photo Founded in 2009, Sea Limited (NYSE:SE) is a leading global consumer internet company that owns brands, namely Shopee, Garena, and Monee. While we acknowledge the potential of SE as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
4 minutes ago
- Yahoo
Summit Therapeutics (SMMT) Nosedives 9% on Dismal Earnings, Absence of Investor Call
We recently published Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the worst-performing stocks on Tuesday. Summit Therapeutics tumbled by 9.08 percent on Tuesday to close at $25.68 apiece as investor sentiment was dampened by a dismal earnings performance as well as the absence of an investor call to elaborate on the results. Summit Therapeutics Inc. (NASDAQ:SMMT), which usually reports its quarterly earnings alongside an investor call, decided go without the latter on Monday. In the second quarter of the year, Summit Therapeutics Inc. (NASDAQ:SMMT) widened its net loss by 836 percent to $565.7 million from $60.4 million in the same period last year, as total operating expenses soared by 853 percent to $568.4 million from $59.6 million year-on-year. Net loss in the first half also expanded by 505 percent to $628.6 million from $103.9 million year-on-year, as total operating expenses jumped 522 percent to $635.3 million from $102 million. Copyright: nicoletaionescu / 123RF Stock Photo Summit Therapeutics Inc. (NASDAQ:SMMT) also skipped to comment on its financial and operating results. While we acknowledge the potential of SMMT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . Sign in to access your portfolio
